drugset / Trial / NCT04188392
Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder
NaSingle-groupOpen-labelTreatment
Summary
This preliminary, open-label study assesses the feasibility of 34mg at bedtime for 6 weeks in Veterans with Posttraumatic Stress Disorder and insomnia.
Timeline
- Start
- 2020-01-06
- Primary completion
- 2021-10-27
- Completion
- 2021-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pimavanserin | Small molecule | 34 mg | — |